Das Anthony Vipin, Kadam Yogita, Tyagi Mudit
Department of eyeSmart EMR & AEye, L V Prasad Eye Institute, Hyderabad, IND.
Srimathi Kanuri Santhamma Centre for Vitreoretinal Diseases, L V Prasad Eye Institute, Hyderabad, IND.
Cureus. 2022 Jun 16;14(6):e25982. doi: 10.7759/cureus.25982. eCollection 2022 Jun.
To describe the demographics and clinical profile of synchysis scintillans in patients presenting to a multitier ophthalmology hospital network in India.
This cross-sectional hospital-based study included 3,082,727 new patients presenting between August 2010 and December 2021. Patients with a clinical diagnosis of synchysis scintillans in at least one eye were included as cases. The data were collected using an electronic medical record system.
Overall, 93 (0.003%) patients were diagnosed with synchysis scintillans. About half of the patients were male (50.54%) and had unilateral (81.72%) affliction. The most common age group at presentation was during the seventh decade of life with 38 (40.86%) patients. The overall prevalence was higher in patients from a higher socioeconomic status (0.003%) presenting from the metropolitan geography (0.005%) and in retired individuals (0.018%). A systemic history of diabetes mellitus was documented in 13 (13.98%) patients and hypertension was documented in 15 (16.13%) patients. The majority of the eyes had mild or no visual impairment (<20/70) in 74 (67.27%) eyes. The most commonly associated ocular comorbidity was cataract in 61 (55.45%) eyes followed by glaucoma in eight (7.27%) eyes. Among the surgical interventions performed for the ocular comorbidities, cataract surgery was performed in nine (8.18%) eyes, and vitreoretinal surgery and trabeculectomy were performed in two (1.82%) eyes each.
Synchysis scintillans equally affect males and females presenting during the seventh decade of life and is predominantly unilateral. The majority of the eyes have mild or no visual impairment and over half of the eyes have an associated cataract.
描述印度一家多层眼科医院网络中出现闪辉性玻璃体液化患者的人口统计学和临床特征。
这项基于医院的横断面研究纳入了2010年8月至2021年12月期间就诊的3082727名新患者。至少一只眼睛有闪辉性玻璃体液化临床诊断的患者被纳入病例组。数据通过电子病历系统收集。
总体而言，93名（0.003%）患者被诊断为闪辉性玻璃体液化。约一半患者为男性（50.54%），且为单侧患病（81.72%）。就诊时最常见的年龄组为70多岁，有38名（40.86%）患者。社会经济地位较高的患者（0.003%）、来自大都市地区的患者（0.005%）以及退休人员（0.018%）的总体患病率更高。13名（13.98%）患者有糖尿病系统病史记录，15名（16.13%）患者有高血压记录。大多数眼睛有轻度或无视力损害（<20/70），74只眼睛（67.27%）如此。最常见的眼部合并症是白内障，61只眼睛（55.45%）有白内障，其次是青光眼，8只眼睛（7.27%）有青光眼。在针对眼部合并症进行的手术干预中，9只眼睛（8.18%）进行了白内障手术，玻璃体视网膜手术和小梁切除术各有2只眼睛（1.82%）进行。
闪辉性玻璃体液化对70多岁的男性和女性影响相同，且主要为单侧。大多数眼睛有轻度或无视力损害，超过一半的眼睛伴有白内障。
